Dr. Lal PathLabs Limited
LALPATHLAB
株式のランク
#4510
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
株価
$20.35
最終同期: 2026-10-19
時価総額
$3.40B
変化（1日）
-0.86%
変化（1年）
13.63%
国
IN
取引 Dr. Lal PathLabs Limited (LALPATHLAB)
カテゴリー
Healthcare
Dr. Lal PathLabs Limited（LALPATHLAB）の利益
Jun 2026 時点の利益 TTM: $79.09M
Dr. Lal PathLabs Limited の最新の財務報告によると、同社の現在の利益は $79.09M です。2024 年には $60.62M の利益を上げ、これは 2023 年の利益 $41.84M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Dr. Lal PathLabs Limited の利益の推移（2011 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $79.09M | 8.27% |
| 2025 | $73.05M | 20.51% |
| 2024 | $60.62M | 44.89% |
| 2023 | $41.84M | -33.14% |
| 2022 | $62.57M | 16.14% |
| 2021 | $53.88M | 30.72% |
| 2020 | $41.22M | -4.77% |
| 2019 | $43.28M | 7.84% |
| 2018 | $40.13M | 9.90% |
| 2017 | $36.52M | 20.54% |
| 2016 | $30.30M | 35.31% |
| 2015 | $22.39M | -3.94% |
| 2014 | $23.31M | 57.92% |
| 2013 | $14.76M | 12.68% |
| 2012 | $13.10M | 30.51% |
| 2011 | $10.04M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $7.61B | 9,520.18% |
US
|
|
| $4.76B | 5,920.67% |
US
|
|
| $-252.70M | -419.49% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 1,996.24% |
US
|
